The New Paper

May 25, 2021

GenSight Biologics publishes study on partially recovered vision for blind man

GenSight Biologics announced the first peer-reviewed documentation of partial visual recovery for a blind patient with late-stage inherited retinal disease. The study used a technique called optogenetics, which uses flashes of light to control gene expression and neuron firing.
This story is from the May 25, 2021 edition of The New Paper. To receive TNP daily subscribe below.

By subscribing, you agree to our Terms of Service & Privacy Policy.